Safety and biomarker effects of solanezumab in patients with Alzheimer’s disease
Titel:
Safety and biomarker effects of solanezumab in patients with Alzheimer’s disease
Auteur:
Farlow, Martin Arnold, Steven E. van Dyck, Christopher H. Aisen, Paul S. Snider, B. Joy Porsteinsson, Anton P. Friedrich, Stuart Dean, Robert A. Gonzales, Celedon Sethuraman, Gopalan DeMattos, Ronald B. Mohs, Richard Paul, Steven M. Siemers, Eric R.